Search

Your search keyword '"Hide, Michihiro"' showing total 343 results

Search Constraints

Start Over You searched for: Author "Hide, Michihiro" Remove constraint Author: "Hide, Michihiro" Database Unpaywall Remove constraint Database: Unpaywall
343 results on '"Hide, Michihiro"'

Search Results

1. The Bruton’s Tyrosine Kinase Inhibitor Remibrutinib Exhibits No Impact on Serum Immunoglobulin Levels: Insights from Chronic Spontaneous Urticaria (P10-6.018)

2. Safety of Remibrutinib Across Immune-mediated Diseases Supports Development in Multiple Sclerosis (P8-6.015)

3. A core outcome set for efficacy of acute treatment of hereditary angioedema

4. Survey of hereditary angioedema episodes and quality of life impairment through a patient-participatory registry

5. Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trial

7. Efficacy of Remibrutinib in Patients With Chronic Spontaneous Urticaria With or Without Prior Exposure to Biologics in the Phase 3 REMIX-1 and REMIX-2 Studies

8. CRUSE®—An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria

11. Analysis of questionnaire survey to determine worldwide trends in prescriptions of biologics for the treatment of unresponsive chronic urticaria

13. Enhancing evidence-informed policymaking in medicine and healthcare: stakeholder involvement in the Commons Project for rare diseases in Japan

15. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

16. A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative

17. Time Course of Priming Effect of TF Inducers on Synergistic TF Expression and Intra-Cellular Gap Formation of Human Vascular Endothelial Cells via the Extrinsic Coagulation Cascade

20. ISID1357 - Construction of the atopic dermatitis sweat function registry (ADSF Registry) for sweating disturbance in atopic dermatitis evaluated by automatic assessment for skin microstructure and sweating.

21. Remibrutinib: A Novel BTKi in Development for MS With a Favorable Safety Profile in Various Autoimmune Disorders (P7-3.015)

25. Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 study

26. Efficacy and safety of omalizumab in adult patients with wheat-dependent exercise-induced anaphylaxis: Reduction of in vitro basophil activation and allergic reaction to wheat

28. Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B‐PAD study)

30. Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan

32. Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey

33. Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors

34. The expression of prolyl isomerase Pin1 is expanded in the skin of patients with atopic dermatitis and facilitates IL ‐33 expression in HaCaT cells

36. Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria

40. Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2021

44. A survey on subtypes and clinical characteristics of 1061 patients with urticaria in the primary care institutes in Japan

46. English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021

Catalog

Books, media, physical & digital resources